New app and therapy aim to keep pregnant women on opioid treatment
NCT ID NCT06496230
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This early-stage study tested whether a brief therapy program plus a mobile app could help pregnant and postpartum women stay on their buprenorphine medication for opioid use disorder. Fifteen pregnant women took part, attending therapy sessions and using the app for up to 9 months. The goal was to see if the approach was practical and liked by participants, not to prove it works yet.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OPIOID-USE DISORDER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Medical University of South Carolina
Charleston, South Carolina, 29403, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can antimalarials be safely used in early pregnancy? a massive registry seeks answers
- Can a new tool better measure opioid withdrawal?
- Texts and local mentors: a new way to empower teen girls on contraception?
- Giving patients a voice in methadone care: a new approach under the microscope
- Mindfulness during pregnancy: a new way to boost mental health and baby bonding?
- Teaching Moms-to-Be about seafood safety: a new weapon against toxic exposures?